6Torres-Quevedo R,Manterola C,Sanhueza A,et al. Diagnostic properties of a symptoms scale for diagnosing reflux esophagitis. J Clin Epidemio1,2009,62( 11 ) :97-101.
7Stedman CA, Barclay ML. Revieraticle, comparison of the pharmacokinetica, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther,2000,14 ( 8 ) :963-978.
8Ariizumi K,Ohars S,Koike T,et al. Therapeutic effects of 10mg/ day raberazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism. J Gastroenterol Hepatol, 2006,21 (9) :1428-1434.
9Graham DY, Yamaoka Y, Malaty HM. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter,2007,12 ( Suppl 2 ) :64-68.
10De Francesco V,Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication:a randomised study. Digesitve and Liver Disease,2001,33 (8) :676-679.
